Comparison of Ridaforolimus‐Eluting and Zotarolimus‐Eluting Coronary Stents: 5‐Year Outcomes From the BIONICS and NIREUS Trials
- DOI
- 10.1161/jaha.124.036210
- Published
- 2024-11-19
- Container
- Journal of the American Heart Association
- Publisher
- Ovid Technologies (Wolters Kluwer Health)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1161/jaha.124.036210,
title = {Comparison of Ridaforolimus‐Eluting and Zotarolimus‐Eluting Coronary Stents: 5‐Year Outcomes From the BIONICS and NIREUS Trials},
author = {Lior Zornitzki and Pieter C. Smits and Michael P. Love and Gregg W. Stone and David E. Kandzari and Bjorn Redfors and Melek O. Ozan and Maayan Konigstein},
year = {2024},
journal = {Journal of the American Heart Association},
doi = {10.1161/jaha.124.036210},
url = {https://doi.org/10.1161/jaha.124.036210}
}RIS
TY - JOUR TI - Comparison of Ridaforolimus‐Eluting and Zotarolimus‐Eluting Coronary Stents: 5‐Year Outcomes From the BIONICS and NIREUS Trials AU - Lior Zornitzki AU - Pieter C. Smits AU - Michael P. Love AU - Gregg W. Stone AU - David E. Kandzari AU - Bjorn Redfors AU - Melek O. Ozan AU - Maayan Konigstein PY - 2024 JO - Journal of the American Heart Association DO - 10.1161/jaha.124.036210 UR - https://doi.org/10.1161/jaha.124.036210 ER -
APA
Zornitzki, L., Smits, P. C., Love, M. P., Stone, G. W., Kandzari, D. E., Redfors, B., Ozan, M. O., & Konigstein, M. (2024). Comparison of Ridaforolimus‐Eluting and Zotarolimus‐Eluting Coronary Stents: 5‐Year Outcomes From the BIONICS and NIREUS Trials. Journal of the American Heart Association. https://doi.org/10.1161/jaha.124.036210
Source records
- crossref · retrieved 2026-09-26T07:36:25.372Z